Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01546467
Other study ID # 2010/1788 (REK)
Secondary ID
Status Recruiting
Phase N/A
First received January 12, 2012
Last updated March 1, 2012
Start date September 2009
Est. completion date December 2013

Study information

Verified date March 2012
Source Oslo University Hospital
Contact Torill Ueland, PhD
Phone +47 22118370
Email torill.ueland@medisin.uio.no
Is FDA regulated No
Health authority Norway:National Committee for Medical and Health Research EthicsNorway: Data Protection AuthorityNorway: Directorate of Health
Study type Interventional

Clinical Trial Summary

The purpose of the study is to investigate the effect of a 30 hour cognitive remediation program for young patients with early phase schizophrenia spectrum disorders on cognitive, clinical and functional outcome measures. The remediation program is integrated with whatever active rehabilitation the participant is currently attending (school, work, day program etc).


Recruitment information / eligibility

Status Recruiting
Enrollment 50
Est. completion date December 2013
Est. primary completion date December 2013
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria:

- Early phase schizophrenia, schizoaffective disorder, psychosis NOS

- Less than 5 years since start of adequate treatment for psychotic disorder

- Age between 18-40

- Norwegian speaking (sufficiently to understand and complete assessments)

Exclusion Criteria:

- Traumatic brain injury

- Neurological disorder as determined by medical history

- IQ below 70

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment


Intervention

Behavioral:
Cognitive remediation
Cognitive remediation including feedback from neurocognitive assessment, psychoeducation about cognitive deficits, 30 hours of computer based drill and practise and strategy coaching based cognitive remediation, 1-3 collaborative meetings with cognitive specialist, participant, therapist and teacher, occupational therapist or other therapist (depending on participants rehabilitation situation) to enhance transfer of skills to daily functioning

Locations

Country Name City State
Norway Psychosis Research Unit, Division of Mental Health and Addiction, Oslo University Hospital. Oslo

Sponsors (3)

Lead Sponsor Collaborator
Oslo University Hospital South-Eastern Norway Regional Health Authority, Stiftelsen Helse og Rehabilitering

Country where clinical trial is conducted

Norway, 

Outcome

Type Measure Description Time frame Safety issue
Primary MATRICS Consensus Cognitive Battery (MCCB) Included in the MCCB are measures of the following cognitive domains: Speed of Processing, Attention, Working memory, Verbal learning, Visual Learning, Reasoning and problem solving and Social Cognition. In addition the following tests are included: HVLT-R and BVMT-R delayed recall to measure memory, TMTB (Halstead Reitan) and Color Word Inteference Test (D-KEFS) to measure executive functioning), Digit span (WAIS-III)to measure working memory, Grooved Pegboard (Halstead Reitan) to measure motor function. Change in MCCB performance from baseline to 4 months and 9 months No
Primary UCSD Performance Based Skilled Assessment Brief Version (UPSA-B) Change in UPSA-B performance from baseline to 4 months and 9 months No
Primary Cognitive Assessment Interview (CAI) Change in CAI scores from baseline to 4 months and 9 months No
Primary Social Functioning Scale (SFS) Change in SFS scores from baseline to 4 months and 9 months No
Secondary Calgary Depression Scale Change in CDS scores from baseline to 4 months and 9 months No
Secondary Global Assessment of Function (GAF)- split version Change in GAF scores from baseline to 4 months and 9 months No
Secondary event related fMRI Event-related fMRI will be performed to measure neuronal activity during a spatial working memory tasks and an executive planning task. All fMRI data will be collected on UllevÄl`s 3 T General Electric Sigma HDx scanner. Change in BOLD fMRI signal from baseline to 4 months No
Secondary Rosenberg Self-Esteem Scale (RSES) Change in RSES scores from baseline to 4 months and 9 months No
See also
  Status Clinical Trial Phase
Recruiting NCT05039489 - A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia N/A
Completed NCT05111548 - Brain Stimulation and Cognitive Training - Efficacy N/A
Completed NCT05321602 - Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder Phase 1
Completed NCT04503954 - Efficacy of Chronic Disease Self-management Program in People With Schizophrenia N/A
Completed NCT02831231 - Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium Phase 1
Completed NCT05517460 - The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center N/A
Completed NCT03652974 - Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy Phase 4
Recruiting NCT04012684 - rTMS on Mismatch Negativity of Schizophrenia N/A
Recruiting NCT04481217 - Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia N/A
Completed NCT00212784 - Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935) Phase 3
Completed NCT04092686 - A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia Phase 3
Completed NCT01914393 - Pediatric Open-Label Extension Study Phase 3
Recruiting NCT03790345 - Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics Phase 2/Phase 3
Recruiting NCT05956327 - Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training N/A
Terminated NCT03261817 - A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders N/A
Terminated NCT03209778 - Involuntary Memories Investigation in Schizophrenia N/A
Completed NCT02905604 - Magnetic Stimulation of the Brain in Schizophrenia or Depression N/A
Recruiting NCT05542212 - Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia N/A
Completed NCT04411979 - Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia N/A
Terminated NCT03220438 - TMS Enhancement of Visual Plasticity in Schizophrenia N/A